BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bozon A, Jeantet G, Rivière B, Funakoshi N, Dufour G, Combes R, Valats JC, Delmas S, Serre JE, Bismuth M, Ramos J, Le Quintrec M, Blanc P, Pineton de Chambrun G. Stricturing Crohn’s disease-like colitis in a patient treated with belatacept. World J Gastroenterol 2017; 23(48): 8660-8665 [PMID: 29358873 DOI: 10.3748/wjg.v23.i48.8660]
URL: https://www.wjgnet.com/1007-9327/full/v23/i48/8660.htm
Number Citing Articles
1
George J. Dugbartey, Alp Sener. Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology2022; : 255 doi: 10.1007/978-3-031-12398-6_15
2
BelataceptReactions Weekly 2018; 1686(1): 76 doi: 10.1007/s40278-018-41140-7
3
Merel M. Tielemans, Gerben A.J. van Boekel, Teun van Gelder, Eric T. Tjwa, Luuk B. Hilbrands. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patientsTransplantation Reviews 2019; 33(2): 55 doi: 10.1016/j.trre.2018.11.001
4
Simon Ville, Diego Cantarovich. Belatacept and Autoimmune Adverse EventsTransplantation 2018; 102(7): e355 doi: 10.1097/TP.0000000000002247
5
Paul Gabarre, Christopher Loens, Yanis Tamzali, Benoit Barrou, Frédéric Jaisser, Jérôme Tourret. Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequencesAmerican Journal of Transplantation 2022; 22(4): 1014 doi: 10.1111/ajt.16836